Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

Author
Aykan, Faruk
Sevinc, Alper
Akbulut, Hakan
Yuce, Deniz
Hayran, Mutlu
Kilickap, Saadettin
Demirag, Guzin
Coskun, Hasan Senol
Karabulut, Bulent
Evrensel, Turkkan
Ustaoglu, Mehmet Ali
Ozdemir, Feyyaz
Turna, Hande
Yavuzsen, Tugba
Yalcin, Suayib
Dane, Faysal
Oksuzoglu, Berna
Yildirim, Nuriye
Isikdogan, Abdurrahman
Ozkan, Metin
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/84896
https://doi.org/10.1200/jco.2018.36.4_suppl.346
Collections